{"id":"W2774227900","doi":"10.1016/j.ejca.2017.10.021","title":"Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"F. Hoffmann-La Roche; Roche","keywords":"Pertuzumab; Anthracycline; Trastuzumab; Medicine; Oncology; Internal medicine; Chemotherapy; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005872987,0.002131372,0.003644009,0.0005068023,0.0006460848,0.001880585,0.001433719,0.002561379,0.005252973],"category_scores_gemma":[0.005382767,0.0009817722,0.003677592,0.0005866233,0.002436698,0.002116632,0.001000219,0.005313793,0.00131742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001464947,"about_ca_system_score_gemma":0.001575722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001045086,"about_ca_topic_score_gemma":0.002024158,"domain_scores_codex":[0.9968798,0.001952795,0.0001318682,0.0004523935,0.0002149671,0.0003681323],"domain_scores_gemma":[0.9943951,0.001606119,0.001385755,0.0007097399,0.0003364938,0.00156671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830385,0.004632908,0.001902448,0.0001361725,0.001700107,0.0000350872,0.00005498303,0.000451557,0.001960589,0.00006675999,0.0004801555,0.005540653],"study_design_scores_gemma":[0.8896674,0.09666484,0.01046166,0.00001772735,0.001547691,0.00005858634,0.00003982459,0.0004036259,0.0003933706,0.0001758572,0.0005384071,0.00003102797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932051,0.001809768,0.0005683387,0.0004879624,0.0002051402,0.0009098698,0.001362005,0.00006669525,0.001385087],"genre_scores_gemma":[0.99123,0.0008410622,0.0007499043,0.0009197471,0.0005023105,0.00129605,0.002593293,0.00003900273,0.001828644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005872987,"threshold_uncertainty_score":0.03105968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02363119783183756,"score_gpt":0.3797801121478566,"score_spread":0.356148914316019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}